Yes, Airduso Is a Steroid Inhaler
Airduso (fluticasone propionate and salmeterol) is a combination inhaler that contains fluticasone, an inhaled corticosteroid (ICS), paired with salmeterol, a long-acting beta-agonist (LABA). The steroid component reduces airway inflammation in asthma and COPD, while the LABA relaxes airway muscles for better breathing.[1]
How Does Airduso Work?
Fluticasone binds to glucocorticoid receptors in lung cells, suppressing inflammatory cytokines and immune responses. Salmeterol provides 12-hour bronchodilation by stimulating beta-2 receptors. Used twice daily, it controls symptoms rather than offering quick relief.[1][2]
What Conditions Does It Treat?
FDA-approved for asthma maintenance in patients 12+ and COPD management. Not for acute attacks—requires a separate rescue inhaler like albuterol.[1]
Common Side Effects Patients Report
Oral thrush (rinse mouth after use), hoarseness, headache, cough. Rare risks include pneumonia in COPD patients or slowed growth in children. Long-term high-dose ICS use may weaken bones or raise eye pressure.[1][2]
How Does It Compare to Other Inhalers?
| Inhaler | Steroid | LABA | Key Difference |
|---------|---------|------|---------------|
| Airduso | Fluticasone | Salmeterol | Dry powder; generic available |
| Advair | Fluticasone | Salmeterol | Same drug, branded version |
| Symbicort | Budesonide | Formoterol | Suspension mist; faster onset |
| Breo | Fluticasone furoate | Vilanterol | Once-daily |
Airduso is the authorized generic of Advair Diskus.[1]
Who Makes Airduso and What's the Cost?
Teva Respiratory manufactures it. Without insurance, a 30-day supply (60 mcg/25 mcg) costs $150–$250; generics lower prices vs. brand. Check GoodRx for coupons.[2]
When Do Patents Expire?
Key patents on fluticasone/salmeterol combos expired in 2019–2021, enabling generics like Airduso. No major exclusivity remains, though device patents may linger.[3]
[1]: FDA Label for Airduso
[2]: Drugs.com - Airduso
[3]: DrugPatentWatch.com - Fluticasone/Salmeterol Patents